FDA Peptide Reclassification 2026: What It Means for Patients in Miami (Patient Guide Edition)
Last updated: June 10, 2026 Quick Answer: The FDA’s 2026 peptide reclassification removes several widely used compounded peptides from the category of bulk drug substances that compounding pharmacies can legally use. For patients in Miami currently receiving peptide therapy, this means some treatments may become harder to access, more expensive, or require a switch to…